I am a
Home I AM A Search Login

Papers of the Week


January 27, 2023


BMC Infect Dis


http://www.ncbi.nlm.nih.gov/pubmed/36670365?dopt=Abstract


23


1

Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial.

Authors

Kjellberg A, Hassler A, Boström E, El Gharbi S, Al-Ezerjawi S, Kowalski J, Rodriguez-Wallberg KA, Bruchfeld J, Ståhlberg M, Nygren-Bonnier M, Runold M, Lindholm P
BMC Infect Dis. 2023 Jan 20; 23(1):33.
PMID: 36670365.

Abstract

With ~ 50 million individuals suffering from post-COVID condition (PCC), low health related quality of life (HRQoL) is a vast problem. Common symptoms of PCC, that persists 3 months from the onset of COVID-19 are fatigue, shortness of breath and cognitive dysfunction. No effective treatment options have been widely adopted in clinical practice. Hyperbaric oxygen (HBO) is a candidate drug.